🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main objective is to determine whether a low-dose regimen of apixaban (...
Status
Completed
Location
Medical university of Graz
Start Date
2018-10-11
Trial ID
NCT03692065
Treatments Being Tested
The purpose of this study is to assess the pharmacokinetics of a single ora...
Status
Completed
Location
Multiple Locations
Start Date
2011-06
Trial ID
NCT01340586
To evaluate the effect of food on the pharmacokinetics of apixaban administ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-09
Trial ID
NCT01437839
In renally impaired patients with acute venous thromboembolism (VTE), stand...
Status
Terminated
Location
CH ARRAS
Start Date
2016-10-19
Trial ID
NCT02664155
Treatments Being Tested
This was an open-label, randomized, single-dose, two-period, two-sequence, ...
Status
Completed
Location
PT Equilab International
Start Date
2021-04-15
Trial ID
NCT06817811
The goal of this clinical trial is to evaluate the pharmacokinetic profiles...
Status
Completed
Location
Novum Pharmaceutical Research Services
Start Date
2022-12-05
Trial ID
NCT05995119
Treatments Being Tested
Patients with acute ST-segment elevation myocardial infarction (STEMI) have...
Status
Completed
Location
Hadassah Medical Organization
Start Date
2018-01-01
Trial ID
NCT03232398
Treatments Being Tested
The purpose of this study is to assess the bioavailability of Apixaban oral...
Status
Completed
Location
Healthcare Discoveries, LLC D/B/A Icon Development Solutions
Start Date
2011-10
Trial ID
NCT02034591
Treatments Being Tested
The purpose of this study is to learn if BMS-562247 can prevent blood clots...
Status
Completed
Location
Local Institution
Start Date
2004-10
Trial ID
NCT00097357
Treatments Being Tested
This study is designed to compare the safety and effectiveness of two blood...
Status
Completed
Location
The James Comprehensive Cancer Center
Start Date
2014-12-10
Trial ID
NCT02295475